Oral pharmaceutical preparation released at infragastrointestinal tract
    2.
    发明授权
    Oral pharmaceutical preparation released at infragastrointestinal tract 失效
    口服药物制剂在肠胃肠道释放

    公开(公告)号:US5468503A

    公开(公告)日:1995-11-21

    申请号:US78294

    申请日:1993-06-25

    IPC分类号: A61K9/48 A61K9/52 A61K9/62

    摘要: An oral pharmaceutical preparation of a type released at infragastrointestinal tract was successfully prepared, wherein a solid organic acid dissolvable, in the form of a solution, of chitosan and a solid pharmaceutical preparation including a principal agent are filled in a hard capsule composed of the base principally comprising chitosan and an enteric coating is formed on the surface of the hard capsule, characterized in that a desirable releasing time can be arranged, with no pH dependency, via water permeability derived from the porosity of chitosan of the capsule preparation.

    摘要翻译: PCT No.PCT / JP92 / 01037 Sec。 371日期:1993年6月25日 102(e)1993年6月25日PCT于1992年8月13日提交PCT成功制备了在胃肠道释放的类型的口服药物制剂,其中固体有机酸以溶液的形式溶解于壳聚糖和 将包含主剂的固体药物制剂填充在由主要包含壳聚糖的基质组成的硬胶囊中,并且在硬胶囊的表面上形成肠溶衣,其特征在于可以布置理想的释放时间,没有pH依赖性 ,通过由胶囊制剂的壳聚糖的孔隙度导致的透水性。

    Therapeutic agent for hemorrhoidal disease
    3.
    发明授权
    Therapeutic agent for hemorrhoidal disease 有权
    痔疮疾病治疗剂

    公开(公告)号:US08183232B2

    公开(公告)日:2012-05-22

    申请号:US10545910

    申请日:2004-02-17

    IPC分类号: A61K31/19

    CPC分类号: A61K31/616 A61K9/0031

    摘要: An external preparation containing acetylsalicylic acid or its pharmaceutically acceptable salt as an active ingredient for treating anal diseases having therapeutic activity on hemorrhoids (internal hemorrhoid, external hemorrhoid), hemorrhoidal disease owing to anal fissure and other anal diseases together with activity on pain and pruritus.

    摘要翻译: 含有乙酰水杨酸或其药学上可接受的盐作为有效成分的外用制剂,用于治疗对痔疮具有治疗活性的肛门疾病(内痔疮,外痔疮),由于肛裂引起的痔疮疾病及其他肛门疾病以及疼痛和瘙痒的活动。

    APPARATUS FOR SIMULATIVELY MEASURING ENVIRONMENT OF WOUND DRESSING ON SKIN AND MEASURING METHOD THEREFOR
    4.
    发明申请
    APPARATUS FOR SIMULATIVELY MEASURING ENVIRONMENT OF WOUND DRESSING ON SKIN AND MEASURING METHOD THEREFOR 有权
    用于模拟测量环境中的皮肤接触环境的装置及其测量方法

    公开(公告)号:US20100326217A1

    公开(公告)日:2010-12-30

    申请号:US12918367

    申请日:2008-02-21

    IPC分类号: G01N33/00

    摘要: There are provided an apparatus and a method for simulatively measuring an environment in a microspace between a human skin and a wound dressing. The simulative environment-measuring apparatus comprises a constant temperature-and-humidity chamber 14 for controlling an external environment; a heat exchanger 12 disposed in the chamber 14; a constant temperature water bath 10 and a pump 11 for supplying warm water to the heat exchanger; and a container 1 which is set on the heat exchanger 12 and is easily detachable therefrom. The container 1 holds a water retentive member 2 therein, and is covered at its upper opening with a water vapor diffusion-controlling member 4. A microspace 6 formed between the water vapor diffusion-controlling member 4 and a wound dressing 5 placed on the member 4 is a simulatively reproduced space between a human skin and the wound dressing 5. A thin temperature-and-humidity sensor 7 is set in this microspace 6 to measure temperature and humidity with time. When plural containers 1 are used, environments of plural wound dressings 5 can be measured at once.

    摘要翻译: 提供了一种用于模拟测量人皮肤和伤口敷料之间的微空间中的环境的装置和方法。 模拟环境测量装置包括用于控制外部环境的恒温恒湿室14; 设置在室14中的热交换器12; 恒温水浴10和用于向热交换器供给温水的泵11; 以及设置在热交换器12上并容易拆卸的容器1。 容器1在其中保持保水构件2,并在其上开口处用水蒸气扩散控制构件4覆盖。形成在水蒸气扩散控制构件4和放置在构件上的伤口敷料5之间的微空间6 图4是人皮肤和伤口敷料5之间的模拟再现空间。在该微空间6中设置薄温湿度传感器7,以随时间测量温度和湿度。 当使用多个容器1时,可以一次测量多个伤口敷料5的环境。

    Butenafine hydrochloride-containing aqueous patch
    7.
    发明授权
    Butenafine hydrochloride-containing aqueous patch 有权
    含有含盐酸布那他汀的水性贴剂

    公开(公告)号:US08377476B2

    公开(公告)日:2013-02-19

    申请号:US12936815

    申请日:2009-03-24

    IPC分类号: A61F13/00 A61K9/70

    摘要: Disclosed is a water-based adhesive skin patch which has excellent storage stability, can achieve excellent accumulation of butenafine hydrochloride contained therein on a patched area such as the skin and a nail, and has a high therapeutic effect. Specifically disclosed is a water-based adhesive skin patch containing butenafine hydrochloride, which is characterized by containing butenafine hydrochloride, glycol salicylate and propylene glycol in a water-containing gel ointment. Specifically, butenafine hydrochloride is dissolved in a mixed solution of glycol salicylate and propylene glycol, and the resulting solution is dispersed in a water-containing gel. Particularly, the mixing ratio of glycol salicylate to propylene glycol is 1:2 to 1:30.

    摘要翻译: 公开了一种水性粘合性皮肤贴剂,其具有优异的储存稳定性,可以在皮肤和钉子等修补区域上实现含有其中所含的盐酸布他他芬的优异积累,并且具有高治疗效果。 具体公开了含有盐酸布替萘芬的水性粘合性皮肤贴剂,其特征在于在含水凝胶软膏中含有盐酸丁酸,二水杨酸乙酯和丙二醇。 具体地说,将盐酸丁丙
    锭溶于水杨酸二乙酯和丙二醇的混合溶液中,将所得溶液分散在含水凝胶中。 特别地,二醇水杨酸酯与丙二醇的混合比为1:2〜1:30。

    Butenafine Hydrochloride-Containing Aqueous Patch
    8.
    发明申请
    Butenafine Hydrochloride-Containing Aqueous Patch 有权
    含有盐酸丁酸的含水补片

    公开(公告)号:US20110097407A1

    公开(公告)日:2011-04-28

    申请号:US12936815

    申请日:2009-03-24

    IPC分类号: A61K9/14 A61K31/13

    摘要: Disclosed is a water-based adhesive skin patch which has excellent storage stability, can achieve excellent accumulation of butenafine hydrochloride contained therein on a patched area such as the skin and a nail, and has a high therapeutic effect. Specifically disclosed is a water-based adhesive skin patch containing butenafine hydrochloride, which is characterized by containing butenafine hydrochloride, glycol salicylate and propylene glycol in a water-containing gel ointment. Specifically, butenafine hydrochloride is dissolved in a mixed solution of glycol salicylate and propylene glycol, and the resulting solution is dispersed in a water-containing gel. Particularly, the mixing ratio of glycol salicylate to propylene glycol is 1:2 to 1:30.

    摘要翻译: 公开了一种水性粘合性皮肤贴剂,其具有优异的储存稳定性,可以在皮肤和钉子等修补区域上实现含有其中所含的盐酸布他他芬的优异积累,并且具有高治疗效果。 具体公开了含有盐酸布替萘芬的水性粘合性皮肤贴剂,其特征在于在含水凝胶软膏中含有盐酸丁酸,二水杨酸乙酯和丙二醇。 具体地说,将盐酸丁丙
    锭溶于水杨酸二乙酯和丙二醇的混合溶液中,将所得溶液分散在含水凝胶中。 特别地,二醇水杨酸酯与丙二醇的混合比为1:2〜1:30。